Price Chart

Key Stats

Net Expense Ratio Discount or Premium to NAV Total Assets Under Management 30-Day Average Daily Volume
0.29% 0.01% 866096.0 1864.93
Dividend Yield Turnover Ratio 1 Year Fund Level Flows Max Drawdown (Since Inception)
0.00% -- 508435.0 Upgrade

Basic Info

Investment Strategy
The investment seeks to track the performance, before fees and expenses, of the Solactive U.S. R&D Champions Index. The index is designed to provide exposure to U.S. companies in the large- and mid- capitalization segments that rank in the top 50 companies based on the index Provider’s R&D intensity metric. The fund will invest, under normal circumstances, at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in securities that comprise the index. The fund is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Growth
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Large Blend
Category Index --
Global Category Name US Equity Large Cap Blend
YCharts Categorization US Large Cap Blend
YCharts Benchmark S&P 500 Total Return (^SPXTR)
Prospectus Objective Growth
Fund Owner Firm Name Themes ETF Trust
Prospectus Benchmark Index
Solactive US R&D Champions Index TR USD 100.0%
Broad Asset Class Benchmark Index
^SPXTR 100.0%
Manager Tenure
Calvin Tsang 0.39 yrs
Dingxun(Kevin) Shao 0.39 yrs

Performance Versus Category

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (Price)
--
--
--
--
--
--
--
--
Total Return (NAV)
--
--
--
--
--
--
--
--
Category Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Cat (NAV)
--
--
--
--
--
--
--
--
As of May 17, 2024. Returns for periods of 1 year and above are annualized.

Annual Total Returns Versus Peers

Loading chart...
Name
2017
2018
2019
2020
2021
2022
2023
YTD
--
--
--
--
--
--
--
9.56%
21.83%
-4.38%
31.49%
18.40%
28.71%
-18.11%
26.29%
11.80%
21.70%
-4.56%
31.22%
18.37%
28.75%
-18.17%
26.19%
11.74%
22.90%
-3.28%
31.42%
22.10%
27.79%
-19.89%
29.79%
12.41%
20.89%
-3.88%
31.15%
20.94%
31.32%
-21.71%
28.52%
11.17%
21.53%
-4.88%
31.06%
20.77%
26.32%
-19.19%
26.41%
11.26%
As of May 17, 2024.

Asset Allocation

As of May 16, 2024.
Type % Net % Long % Short
Cash 0.26% Upgrade Upgrade
Stock 99.74% Upgrade Upgrade
Bond 0.00% Upgrade Upgrade
Convertible 0.00% Upgrade Upgrade
Preferred 0.00% Upgrade Upgrade
Other 0.00% Upgrade Upgrade

Basic Info

Investment Strategy
The investment seeks to track the performance, before fees and expenses, of the Solactive U.S. R&D Champions Index. The index is designed to provide exposure to U.S. companies in the large- and mid- capitalization segments that rank in the top 50 companies based on the index Provider’s R&D intensity metric. The fund will invest, under normal circumstances, at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in securities that comprise the index. The fund is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Growth
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Large Blend
Category Index --
Global Category Name US Equity Large Cap Blend
YCharts Categorization US Large Cap Blend
YCharts Benchmark S&P 500 Total Return (^SPXTR)
Prospectus Objective Growth
Fund Owner Firm Name Themes ETF Trust
Prospectus Benchmark Index
Solactive US R&D Champions Index TR USD 100.0%
Broad Asset Class Benchmark Index
^SPXTR 100.0%
Manager Tenure
Calvin Tsang 0.39 yrs
Dingxun(Kevin) Shao 0.39 yrs

Top Portfolio Holders

0 of 0